GLP1R and medullary thyroid gland carcinoma: GLP1‐RAs and GLP‐1RA/GIPs are medications that are contraindicated in older adults with a past medical history of multiple endocrine neoplasia syndrome type 2 (MEN‐2) and a family history of medullary thyroid cancer (MTC) or in patients with a history of pancreatitis.